Correction to Jazz Pharmaceuticals Story
May 30 2016 - 10:49PM
Dow Jones News
"Jazz Pharmaceuticals Nears Deal to buy Celator Pharmaceuticals
for About $1.5 Billion," published at 9:51 p.m. ET, incorrectly
reported that Jazz was headquartered in California and acquired an
Israeli company in 2012. It now based in Ireland because it
acquired an Irish company that year. (May 30, 2016)
(END) Dow Jones Newswires
May 30, 2016 22:34 ET (02:34 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Feb 2024 to Mar 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2023 to Mar 2024